The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
暂无分享,去创建一个
H. Suryapranata | T. Machnig | G. Linssen | U. Tebbe | U. Zeymer | G. Rasmanis | K. Neuhaus | G. Opolski | H Suryapranata | R Schröder | J P Monassier | R. Schröder | G Opolski | U Zeymer | J Davies | G Rasmanis | G Linssen | U Tebbe | R Tiemann | T Machnig | K L Neuhaus | J. Monassier | R. Tiemann | J. Davies | Karl-Ludwig Neuhaus | U. Tebbe | K. Neuhaus
[1] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[2] E. Braunwald,et al. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.
[3] R. Kloner. Does reperfusion injury exist in humans? , 1993, Journal of the American College of Cardiology.
[4] K. Wegscheider,et al. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study. , 1999, European heart journal.
[5] D. Yellon,et al. Sodium-hydrogen exchange in myocardial reperfusion injury , 2000, The Lancet.
[6] T. Linderer,et al. Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase. , 1998, American heart journal.
[7] G. Ambrosio,et al. Reperfusion injury: experimental evidence and clinical implications. , 1999, American heart journal.
[8] R. Bohle,et al. Myocardial Protection by Na+-H+ Exchange Inhibition in Ischemic, Reperfused Porcine Hearts , 1995 .
[9] M. Simoons,et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.
[10] M. Karmazyn,et al. The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease. , 1999, Circulation research.
[11] Grzegorz Opolski,et al. Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction , 2001, Heart Drug.
[12] C. Fry,et al. Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.
[13] E. Peterson,et al. Effect of clinical factors on length of stay after coronary artery bypass surgery: results of the cooperative cardiovascular project. , 1999, American heart journal.
[14] R. Bohle,et al. Na+/H+ Exchange Inhibitor Cariporide Attenuates Cell Injury Predominantly During Ischemia and Not at Onset of Reperfusion in Porcine Hearts With Low Residual Blood Flow , 2000, Circulation.
[15] P. Thompson,et al. Enzymatic Indices of Myocardial Necrosis: Influence on Short- and Long-Term Prognosis After Myocardial Infarction , 1979, Circulation.
[16] E. Braunwald,et al. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. , 1992, Circulation.
[17] H. White,et al. Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations: Main Results of the GUARDIAN Trial , 2000, Circulation.
[18] G. Gross,et al. Inhibitors of ischemic preconditioning do not attenuate Na+/H+ exchange inhibitor mediated cardioprotection. , 2000, Journal of cardiovascular pharmacology.
[19] F. Sheehan,et al. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. , 2000, Circulation.
[20] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[21] L. Becker,et al. Progression of myocardial necrosis during reperfusion of ischemic myocardium. , 1998, Circulation.
[22] P. Théroux,et al. Myocardial cell protection : a challenging time for action and a challenging time for clinical research. , 2000, Circulation.
[23] G. Gross,et al. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. , 1998, The Journal of pharmacology and experimental therapeutics.
[24] N. Beier,et al. Pharmacokinetic/Pharmacodynamic Evaluation of the NHE Inhibitor Eniporide , 2001, Journal of clinical pharmacology.
[25] M. Avkiran. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. , 1999, The American journal of cardiology.
[26] K. Minck,et al. Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs. , 1995, Cardiovascular research.
[27] R. Reneman,et al. Enzymatic infarct size and its significance for evaluation of thrombolytic therapy after acute myocardial infarction. , 1990, Circulation.